Patients in the immune clearance and reactivation phases, with elevated alanine aminotransferase (ALT) and HBV DNA levels, are candidates for antiviral therapy.

• 处于免疫清除和再次复发阶段的患者，谷丙转氨酶（ALT）和乙肝病毒DNA水平都有所升高，需要进行抗病毒药物治疗。